ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1386

Measurement of TIMP-1 in Pulmonary Vessels May Be a Novel Marker of Reflecting mPAP in CTD-PH

Shusaku Nakashima1, Kaori Ishikawa1, Kiyo Ueeda1, Tomohiro Kameda1, Hiromi Shimada1, Risa Wakiya1, Mansour mai1, Mikiya Kato1, Taichi Miyagi2, Koichi Sugihara1, Rina Semba1, Mao Mizusaki1 and Hiroaki Dobashi3, 1Kagawa University, Takamatsu, Japan, 2Kagawa University, Kidagun, Japan, 3Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

Meeting: ACR Convergence 2021

Keywords: Biomarkers, cytokines, pulmonary, Systemic lupus erythematosus (SLE), Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Session Title: Systemic Sclerosis & Related Disorders – Clinical Poster II (1364–1390)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: CTD is a disease with immune abnormalities which could alter normal cytokine profile. CTD-PH has a different pathogenesis from that of iPAH, and immunosuppressive therapy is effective. These facts suggest that the two PH conditions have different pathologies related to pulmonary artery inflammation. Various cytokine abnormalities have also been reported to be involved in the pathogenesis of CTD-PH. However, the relationship between these cytokine abnormalities and pulmonary artery pressure has not been fully elucidated.

To clarify the relationship between cytokines and mean pulmonary artery pressure by analysis of the cytokine profile in PH patients including CTD-PH. In addition, we will clarify the differences in cytokine profiles between CTD-PH and iPAH.

Methods: Patients who underwent RHC for PH diagnosis at our hospital from 2015 to 2020 years were included in the study. Right heart catheterization and left heart catheterization were tried, and pre- and post-pulmonary sera were collected to measure cytokines. The target cytokines were TIMP-1, MCP-1, IL-17 and IL-21, IL-12p70 and IL-6, which were measured by ELISA (ABCAM UK, Ella simple plex USA). The relationship between the measured cytokine profiles and hemodynamic parameters was compared.

Results: 21 CTD patients (SSc 12 cases, MCTD 7cases, SLE 2 cases) and 13 non-CTD patients were subjected to be analyzed cytokines in pulmonary vessels . As previously reported, there was a positive correlation between serum IL-6 level and mPAP (mean pulmonary arterial pressure) in all our patients, but not observed in CTD patients(Figure1.). Furthermore, serum TIMP-1 level showed a significant correlation with mPAP in all patients. Additionally, this correlation was observed more remarkable in CTD patients compared to non CTD patients (Figure 2.). In addition among CTD patients, serum MCP-1, IL-6, and TIMP-1 level in SSc-PH cases tend to be higher than those in those of non SSc CTD-PH. Serum IL-12p70 and IL-17 level were lower in SSc- PH compared that non SSc CTD-PH. In some CTD cases who were investigated before and after PH treatment, serum IL-17, IL-21, and TIMP-1 level were decreased along with improvement of pulmonary vascular hemodynamics.

Conclusion: The cytokine profile of pulmonary capillaries reflected hemodynamics, the significance of which was different in CTD-PH and iPAH. Measurement of IL-17, IL-21, and TIMP-1 in pulmonary vessels may be useful for diagnosis, monitoring, and evaluation of therapeutic effects in CTD-PH.


Disclosures: S. Nakashima, None; K. Ishikawa, None; K. Ueeda, None; T. Kameda, None; H. Shimada, None; R. Wakiya, None; M. mai, None; M. Kato, None; T. Miyagi, None; K. Sugihara, None; R. Semba, None; M. Mizusaki, None; H. Dobashi, None.

To cite this abstract in AMA style:

Nakashima S, Ishikawa K, Ueeda K, Kameda T, Shimada H, Wakiya R, mai M, Kato M, Miyagi T, Sugihara K, Semba R, Mizusaki M, Dobashi H. Measurement of TIMP-1 in Pulmonary Vessels May Be a Novel Marker of Reflecting mPAP in CTD-PH [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/measurement-of-timp-1-in-pulmonary-vessels-may-be-a-novel-marker-of-reflecting-mpap-in-ctd-ph/. Accessed January 28, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measurement-of-timp-1-in-pulmonary-vessels-may-be-a-novel-marker-of-reflecting-mpap-in-ctd-ph/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences